Century Complete Announces New Homes Now Selling near Ann Arbor, MI

The Timbers offers quality and affordable new homes in Van Buren Township Century Communities, Inc. (NYSE: CCS)-a top national homebuilder, industry leader in online home sales, and featured on America's Most Trustworthy Companies and World's Most Trustworthy Companies by Newsweek-announced that the Company's Century Complete brand is now selling new homes from the mid $300s […]

Missouri American Water Urges Customers to Prepare for Cold Weather

Tips to Protect Pipes Before Freezing Temperatures As winter approaches, Missouri American Water reminds customers to prepare their homes and businesses, providing handy tips to help avoid costly repairs and unwanted stress from frozen water pipes this season. https://mma.prnewswire.com/media/2837782/Missouri_American_Water_Logo.jpg “As temperatures drop, a little preparation goes a long way. Protecting your home's plumbing now helps

Revelstoke Capital-Backed The Care Team Acquires Select Assets of Traditions Health

Expands Its Hospice and Palliative Care Services across the Midwest and MidAtlantic Revelstoke Capital Partners (“Revelstoke”), a growth-oriented, healthcare-focused private equity firm, announced today that its portfolio company, The Care Team, has acquired select hospice and palliative care operations from Traditions Health, a Tennessee-based hospice, palliative, and home health provider with operations in 16 states.

Neurimmune expands collaboration with AstraZeneca to develop and commercialize fibril depleter NI009 for AL amyloidosis

Neurimmune today announced that it has expanded on its transthyretin amyloid cardiomyopathy (ATTR-CM) collaboration with Alexion, AstraZeneca Rare Disease by entering into an exclusive global collaboration and license agreement to develop NI009, a preclinical human monoclonal antibody designed to target and deplete lambda light chain fibrils and deposits from affected tissues and organs in light

Hesai to Exhibit at CES 2026 with Cutting-Edge ADAS and Robotics Lidar Solutions

Hesai Technology (NASDAQ: HSAI; HKEX: 2525), a global leader in lidar solutions, announced today that it will exhibit at the Consumer Electronics Show (CES) 2026 in Las Vegas from January 6-9 (LVCC West Hall #5601). In 2025, Hesai became the world's first lidar company to surpass 2 million cumulative lidar deliveries, enabling large-scale deployments across

Jack T. Diamond Joins GHC Industries as Principal & Chief Strategy Officer

GHC Industries is proud to announce the appointment of Jack T. Diamond as Chief Strategy Officer, marking a pivotal milestone in the company's continued expansion across its healthcare vertical. Mr. Diamond will also become a Principal in the business alongside Ankit Patel, Bhavin “B” Patel, Michael J. Smith, Matt Soble, and Saagar Parikh. https://mma.prnewswire.com/media/2837947/GHC_Industries_CSO_Jack_Diamond.jpg Jack

DBS Named Global Bank of the Year 2025 by The Banker

Acknowledged for exceptional performance and innovative use of technology, including AI and blockchain, to meet the financial needs of customers DBS today announced it has been named Global Bank of the Year 2025 by The Banker, a publication of The Financial Times, at its prestigious Bank of the Year awards. This marks the third time

Madison’s Sawmill Curtailment Lookout: November 2025

The monthly data update ofMadison's Sawmill Curtailment Lookouthas been sent to subscribers. Be among the first to sign up and gain access to this worthwhile knowledge base! Our monthly newsletter publication tracks US and Canadian lumber manufacturer downtime and sawmill curtailment. Every month, straight to your inbox get the most up-to-date report of lumber production

RadioMedix and Thor Medical enter supply agreement for thorium-228

(Oslo Bors:TRMED), OSLO, Norway and HOUSTON, Dec. 04, 2025 (GLOBE NEWSWIRE) — Thor Medical ASA, a leading emerging supplier of alpha-emitters for next-generation precision cancer treatment, and RadioMedix, Inc., a U.S. based clinical-stage biotechnology company focused on innovative targeted radiopharmaceuticals for diagnosis, monitoring and cancer therapy, have entered into a five-year frame agreement for the

Purple Biotech to Present New Preclinical Data from its CAPTN-3 Tri-Specific Antibody Platform at the European Society of Medical Oncology Immuno-Oncology (ESMO-IO) 2025 Annual Congress

(NASDAQ:PPBT),(TASE:PPBT.TA), New data showcase the versatility and anti-tumor activity of the CAPTN-3 platform and its unique multi-arm design in treatment-resistant cancers REHOVOT, Israel, Dec. 04, 2025 (GLOBE NEWSWIRE) — Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance,

Scroll to Top